MAPT and Down syndrome: Phosphorylation of Ser396-404, present in 50% of the total structure of early phosphorylated tau aggregates in brain sections from AD and Down syndrome patients [56], is also thought to be more important for tau events since being found to reduce the solubility of full-length tau and promote aggregation [57].